RWD104 Generalization of the Effectiveness of Baricitinib 4MG Among bDMARD-IR Rheumatoid Arthritis Patients from a RCT to a Real-World Population in China
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2133
https://www.valueinhealthjournal.com/article/S1098-3015(23)02233-7/fulltext
Title :
RWD104 Generalization of the Effectiveness of Baricitinib 4MG Among bDMARD-IR Rheumatoid Arthritis Patients from a RCT to a Real-World Population in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02233-7&doi=10.1016/j.jval.2023.03.2133
First page :
Section Title :
Open access? :
No
Section Order :
11453